Loading...
Convalescent Plasma Therapy: A Passive Therapy for An Aggressive COVID-19
Sahu, Kamal Kant ; Jindal, Vishal ; Siddiqui, Ahmad Daniyal ; Cerny, Jan ; Gerber, Jonathan M
Sahu, Kamal Kant
Jindal, Vishal
Siddiqui, Ahmad Daniyal
Cerny, Jan
Gerber, Jonathan M
Citations
Altmetric:
Student Authors
Faculty Advisor
Academic Program
UMass Chan Affiliations
Document Type
Accepted Manuscript
Publication Date
2020-05-21
Subject Area
Collections
Embargo Expiration Date
Link to Full Text
Abstract
As of May 19, 2020, there are in total 4,986,200 laboratory-confirmed Coronavirus disease-2019 (COVID-19) cases. 2% (45,425) out of 2,657,390 active COVID-19 cases are critically ill and might be requiring intensive care support. Unfortunately, even after six months since its first detection, we still do not have any definitive treatment options for COVID-19 pneumonia. Recently, the use of human convalescent plasma is being considered as a potential option for the treatment of COVID-19.
Source
Sahu KK, Jindal V, Siddiqui AD, Cerny J, Gerber JM. Convalescent Plasma Therapy: A Passive Therapy for An Aggressive COVID-19. J Med Virol. 2020 May 21. doi: 10.1002/jmv.26047. Epub ahead of print. PMID: 32437024. Link to article on publisher's site
Year of Medical School at Time of Visit
Sponsors
Dates of Travel
DOI
10.1002/jmv.26047
Permanent Link to this Item
PubMed ID
32437024
Other Identifiers
Notes
Funding and Acknowledgements
Corresponding Author
Related Resources
Related Resources
Repository Citation
Rights
© 2020. This is a PDF file of an accepted manuscript that has been accepted for publication and posted with a 12-month embargo as allowed by the publisher’s author rights policy at https://authorservices.wiley.com/author-resources/Journal-Authors/licensing/self-archiving.html. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.